-
Featured Authors
-
Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: 2011 BIO International Convention
Five international biotech countries to watch
Scientific American released their third annual WorldView: A Global Biotechnology Perspective at the 2011 BIO International Convention which includes a Bio Innovation Scorecard. The Scorecard reviews individual country biotechnology programs and policies aimed at growing local innovative biotechnology sectors. Based on the results of the Bio Innovation Scorecard, here’s our list of 5 biotechs to watch: 5. Malaysia: Ranking third in the world for the best Enterprise Support of its biotech industry by Scientific American’s Read More >
Managing Biotech Technological Innovation in a New Era
Written by Kelly Cappio, BIO. This session focused on technological innovations and how they can be used to prevent, identify, or respond to new natural or man-made threats. As stated by Dr. Alan Rudolph, “We face a very dynamic threat space.” Dr. Rudolph, Director of the Chemical and Biological Technologies Directorate at the Defense Threat Reduction Agency, discussed the strategic thrust of the agency and its recent focus on new diagnostic technologies, such as MIMIC, Read More >
Biotechnology – Creating a positive political and social environment
“I think it’s important that government stands up for proper science,” Former British Prime Minister Tony Blair said during the Tuesday keynote luncheon at the 2001 BIO International Convention. “You know I had a lot of battles over this when I was prime minister – with various groups.” This was a familiar story to many of the attendees who regularly face a number of social and political hurdles in bringing their innovative products to market: Read More >
USTR: TPP to have High IP Standards to “Stand Alongside other Treaty Agreements in the Area”
Stan McCoy, Assisant U.S. Trade Representative for Intellectual Property and Innovation, spoke at BIO’s 2011 Convention session titled The Trans-Pacific Partnership and the Importance of Intellectual Property Rights: Attracting Investment in Biotechnology. The session covered the ongoing treaty negotiations and the relevance of different IP provisions to the biotechnology industry. Issues of particular importance to the biotechnology industry yet to be revelead to the public include language tabled for data protection and patent linkage. While USTR specific language is not available, Read More >
Podcast: 2011 Dr. Paul Janssen Award winner Dr. Napoleone Ferrara
Dr. Napoleone Ferrara, a Genentech Fellow, was named the 2011 winner of The Dr. Paul Janssen Award for Biomedical Research. Dr. Ferrrara was recognized for his research on angiogenesis, the process of new blood vessel formation, and the isolation and cloning of vascular endothelial growth factor (VEGF), a major regulator of angiogenesis in physiology and disease. Download the podcast
